Advertisement

Payer

Medicare Advantage enrollees received less intensive postacute care than their counterparts in traditional Medicare, but did not have a significant change in short-term outcomes, a study published Feb. 16 in JAMA Health Forum found. 

Advertisement

It has been a busy few weeks for Medicare Advantage policy. CMS proposed a slight cut in benchmark rates, and payer executives were split on the impact of rising costs in the business. 

Medicaid redeterminations began in April 2023, and all major payers have released their 2023 earnings, revealing which recorded the largest enrollment losses in the Medicaid market.

The Cigna Group is buying back $3.2 billion in common stock through accelerated repurchase agreements with Deutsche Bank and Bank of America, the company announced Feb. 15. 

Most private investments in the Medicare Advantage space go to companies specializing in marketing and selling MA plans, according to a Feb. 13 report from the Private Equity Stakeholder Project. 

It's no secret that climate change is already affecting insurance markets in places like Florida — but the health insurance industry could be the next to face rising coverage costs as a result of a warming planet, The Wall Street…

Advertisement